RT Journal Article
SR Electronic
T1 The Lifelines COVID-19 Cohort: a questionnaire-based study to investigate COVID-19 infection and its health and societal impacts in a Dutch population-based cohort
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.19.20135426
DO 10.1101/2020.06.19.20135426
A1 Kate Mc Intyre
A1 Pauline Lanting
A1 Patrick Deelen
A1 Henry Wiersma
A1 Judith M. Vonk
A1 Anil P.S. Ori
A1 Soesma A. Jankipersadsing
A1 Robert Warmerdam
A1 Irene van Blokland
A1 Floranne Boulogne
A1 Marjolein X.L. Dijkema
A1 Johanna C. Herkert
A1 Annique Claringbould
A1 Olivier Bakker
A1 Esteban A. Lopera Maya
A1 Ute Bültmann
A1 Alexandra Zhernakova
A1 Sijmen A. Reijneveld
A1 Elianne Zijlstra
A1 Morris Swertz
A1 Sandra Brouwer
A1 R. van Ooijen
A1 Viola Angelini
A1 Louise Dekker
A1 Anna Sijtsma
A1 Sicco A. Scherjon
A1 Jackie Dekens
A1 Jochen O. Mierau
A1 H. Marike Boezen
A1 Lude Franke
YR 2020
UL http://medrxiv.org/content/early/2020/06/24/2020.06.19.20135426.abstract
AB The COVID-19 pandemic has affected billions of people around the world not only through the infection itself but also through its wider impact on public health and daily life. To assess the effects of the pandemic, a team of researchers across a wide range of disciplines developed and implemented the Lifelines COVID-19 questionnaire, leading to the development of the Lifelines COVID-19 cohort. This cohort is recruited from participants of the Lifelines prospective population cohort and the Lifelines NEXT birth cohort, and participants were asked to fill out detailed questionnaires about their physical and mental health and experiences on a weekly basis starting in late March of 2020 and on a bi-weekly basis staring in June 2020. The Lifelines region covers the three Northern provinces of the Netherlands— Drenthe, Groningen and Friesland—which together account for ∼10% of the Dutch population. To date, >70,000 people have responded to the questionnaires at least once, and the questionnaire program is still ongoing. Data collected by the questionnaires will be used to address four aspects of the outbreak: (1) how the COVID-19 pandemic developed in the three northern provinces of the Netherlands, (2) which environmental risk factors predict disease susceptibility and severity, (3) which genetic risk factors predict disease susceptibility and severity and (4) what are the psychological and societal impacts of the crisis.Informed consent All Lifelines and Lifelines NEXT participants have provided informed consent that provide the opportunity for add-on research.Research involving human participants Both the Lifelines and the Lifelines NEXT studies were approved by the ethics committee of the University Medical Center Groningen.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe Lifelines COVID-19 cohort is self-funded with in cash and in kind contributions from the initiators. LF is supported by a Netherlands Organisation for Scientific Research (NWO) Corona Fast-Track grant (440.20.001), an Oncode Senior Investigator grant, a grant from the European Research Counsel (ERC Starting Grant agreement number 637640 ImmRisk) and an NWO VIDI grant (917.14.374) awarded to LF. AZ is supported by the ERC Starting Grant 715772, NWO-VIDI grant 016.178.056, the Netherlands Heart Foundation CVON grant 2018-27 and the NWO Gravitation grant ExposomeNL 024.004.017.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Both the Lifelines and the Lifelines NEXT studies were approved by the ethics committee of the University Medical Center Groningen.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data is available via the Lifelines biobank, a resource accessible for any researcher. For more information on the Lifelines biobank and data access, please visit https://www.lifelines.nl.